KRAS and familial pancreatic carcinoma: Thus, combined the results from both the testing set and patient-derived pancreatic cancer cell lines demonstrate that after treatment persistent cells displays features associated with a senescence-like state in PDAC and suggest KRAS status as a mediator of this process.